| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/05/1995 | CA2164424A1 Mesothelial cell gene therapy |
| 01/05/1995 | CA2164089A1 Transgenic production of ec-sod |
| 01/04/1995 | EP0632129A1 Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 01/04/1995 | EP0632054A1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 01/04/1995 | EP0631773A1 Cosmetic or dermatologic compositions comprising ribosomes, preparation of the ribosomes, preparation and use of said compositions |
| 01/04/1995 | EP0631633A1 Reaction-based selection for expression of and concentration of catalytic moieties |
| 01/04/1995 | EP0631630A1 Control of male fertility using externally inducible promoter sequences |
| 01/04/1995 | EP0631629A1 Fungus-responsive chimaeric gene |
| 01/04/1995 | EP0631624A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 01/04/1995 | EP0631623A1 Dna encoding taurine and gaba transporters and uses thereof |
| 01/04/1995 | EP0631619A1 Reconstituted cartilage tissue |
| 01/04/1995 | EP0631618A1 Culturing of hematopoietic stem cells and their genetic engineering |
| 01/04/1995 | EP0631617A1 Colon crypt cell mitogen, cell line producing it, and uses thereof |
| 01/04/1995 | EP0435946B1 Methods for modifying the binding of cell adhesion receptors |
| 01/03/1995 | US5378814 Hepatitis delta viral polypeptides |
| 01/03/1995 | US5378620 Streptolysin O derivatives |
| 01/03/1995 | US5378612 Nonionic surfactant, cyclodextrin |
| 01/03/1995 | CA2127178A1 Novel cosmetic or dermatological compositions containing ribosomes, the preparation of ribosomes and preparation of said compositions and their application |
| 01/03/1995 | CA1333778C Method for increasing the expression of polypeptides in recombinant cell culture |
| 12/28/1994 | EP0630405A1 Novel V28 seven transmembrane receptor |
| 12/28/1994 | EP0630403A1 Methods for the regulation of plant fertility |
| 12/28/1994 | EP0527814B1 An immortalized primate hepatocyte cell line |
| 12/28/1994 | EP0382834B1 Superoxide dismutase expression in plants |
| 12/28/1994 | CN1096822A Improved methods for the preparation of endotoxinbinding proteins |
| 12/28/1994 | CN1096820A Method for producing taxusol by cell culture |
| 12/27/1994 | US5376546 Analogs of ribosome-inactivating proteins |
| 12/22/1994 | WO1994029691A1 Preserved, non-infectious control cells prepared by the modulation or modification of normal cells |
| 12/22/1994 | WO1994029478A1 Immunoassay reagents and methods for detecting brequinar and analogs |
| 12/22/1994 | WO1994029472A2 Mengovirus as a vector for expression of foreign polypeptides |
| 12/22/1994 | WO1994029471A1 Adenoviral vectors for treatment of hemophilia |
| 12/22/1994 | WO1994029470A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 12/22/1994 | WO1994029469A2 Plasmids suitable for gene therapy |
| 12/22/1994 | WO1994029458A1 Hybrid receptor molecules |
| 12/22/1994 | WO1994029451A2 Humanised antibodies |
| 12/22/1994 | WO1994029449A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
| 12/22/1994 | WO1994029447A2 Dna coding for the human thyrotropin-releasing hormone receptor |
| 12/22/1994 | WO1994029442A2 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 12/22/1994 | WO1994029440A1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors |
| 12/22/1994 | WO1994029438A1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 12/22/1994 | WO1994029436A1 Methods for selectively stimulating proliferation of t cells |
| 12/22/1994 | WO1994029344A1 Super proteins including interferons and interleukins |
| 12/22/1994 | WO1994029341A1 Methods of enhancing bioactivity of chemokines |
| 12/22/1994 | WO1994028931A1 Methods for treating inflammatory disorders |
| 12/22/1994 | WO1994028721A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| 12/22/1994 | WO1994026889A3 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds |
| 12/22/1994 | WO1994025617A3 Monoclonal antibodies against ck-mb |
| 12/22/1994 | WO1994016075A3 Process for producing m-csf 223 |
| 12/22/1994 | DE4345200A1 Pharmaceutical composition for the treatment of immune reactions |
| 12/22/1994 | CA2164953A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 12/22/1994 | CA2164811A1 Super proteins including interferons and interleukins |
| 12/22/1994 | CA2164732A1 Process for generating male sterile plants |
| 12/22/1994 | CA2164632A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| 12/22/1994 | CA2164623A1 Hybrid receptor molecules |
| 12/22/1994 | CA2164510A1 Immunoassay reagents and methods for detecting brequinar and analogs |
| 12/22/1994 | CA2164297A1 Mengovirus as a vector for expression of foreign polypeptides |
| 12/22/1994 | CA2164131A1 Preserved, non-infectious control cells prepared by the modulation or modification of normal cells |
| 12/22/1994 | CA2163344A1 Humanised antibodies |
| 12/22/1994 | CA2162497A1 Adenoviral vectors for treatment of hemophilia |
| 12/22/1994 | CA2161811A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
| 12/22/1994 | CA2126294A1 Materials and methods for screening anti-osteoporosis agents |
| 12/21/1994 | EP0629700A2 Vector and mammalian cell line having improved productivity |
| 12/21/1994 | EP0629697A2 Materials and methods for screening anti-osteoporosis agents |
| 12/21/1994 | EP0629293A1 Assay for adrenal autoantigen |
| 12/21/1994 | EP0629237A1 Device for cell culture treatment. |
| 12/21/1994 | EP0629206A1 Immunological detection of organophosphates |
| 12/21/1994 | EP0629130A1 Use of interleukin-10 to suppress graft-vs.-host disease |
| 12/21/1994 | EP0629129A1 Method for kidney tubulogenesis |
| 12/21/1994 | CN1096584A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of hla-c-clone 10/mage-1 derived peptides, and method for treating said......... |
| 12/21/1994 | CN1096540A Culture of wall dependent cells using air-lift suspended micro-carrier |
| 12/20/1994 | US5374558 Recombinant DNA comprising promoter sequence in fowlpox virus genome transcribably linked to foreign gene |
| 12/20/1994 | US5374550 Thyroid-derived chondrocyte-stimulating factor |
| 12/20/1994 | US5374549 Treating tumors; culturing with suppression of expansion of adherent lymphokine-activated killer(A-LAK) cells |
| 12/20/1994 | US5374529 Methods of and compositions for diagnosis, monitoring and treating the early stages of osteoarthritis |
| 12/20/1994 | US5374518 Monoclonal antibody for differentiating HIV-2 from HIM-1 seropositive individuals |
| 12/20/1994 | US5374515 Tissue culture system |
| 12/20/1994 | US5374424 Multivalent felv-infected feline vaccine |
| 12/14/1994 | EP0628639A1 Reconstituted human antibody against human interleukin 6 receptor |
| 12/14/1994 | EP0628635A1 Process for generating male sterile plants |
| 12/14/1994 | EP0628084A1 Monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus |
| 12/14/1994 | EP0628074A1 $i(IN VITRO) ACTIVATION OF CYTOTOXIC T CELLS |
| 12/14/1994 | EP0628057A1 Compositions and methods for the treatment of thermal injury |
| 12/14/1994 | EP0628054A1 Car receptors and related molecules and methods |
| 12/14/1994 | EP0627936A1 Feline infectious peritonitis vaccine and method of preparation |
| 12/14/1994 | EP0627934A1 Early antigen for autoimmune diabetes |
| 12/14/1994 | EP0627923A1 Therapeutic domains of von willebrand factor |
| 12/14/1994 | EP0627912A1 Gels for encapsulation of biological materials |
| 12/14/1994 | EP0627911A1 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| 12/14/1994 | EP0573606A4 A native-state histoculturing method for skin. |
| 12/14/1994 | EP0471030B1 Glycoprotein hormone receptor molecules |
| 12/14/1994 | EP0380607B1 Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen |
| 12/14/1994 | EP0101681B1 Antibody to a mediator activity composition and its use in a pharmaceutical composition |
| 12/13/1994 | US5372945 Device and method for collecting and processing fat tissue and procuring microvessel endothelial cells to produce endothelial cell product |
| 12/13/1994 | US5372943 Lipid microemulsions for culture media |
| 12/13/1994 | US5372933 Antibody-polypeptide immunocomplex |
| 12/13/1994 | US5372809 Antigenic matrix metalloproteinase peptides |
| 12/08/1994 | WO1994028424A1 Method for selection of biologically active peptide sequences |
| 12/08/1994 | WO1994028391A1 Ligands for flt3 receptors |
| 12/08/1994 | WO1994028170A1 Process for screening substances having a modulating effect on an interleukine-5-receptor-dependent cellular signal transmission path |
| 12/08/1994 | WO1994028161A1 Antibodies specific for dcc gene product |
| 12/08/1994 | WO1994028158A1 Antimucoglycoprotein monoclonal antibody |